InsiderClue
Insiders · Profile

Davidson Michael H.

Chief Executive Officer at NewAmsterdam Pharma Co N.V · Director at TENAX THERAPEUTICS · Director at LISATA THERAPEUTICS. Filing since 9 Sep 2020. CIK 0001573785

NAMS NewAmsterdam Pharma Co N.V. Chief Executive Officer · 9 trades TENX TENAX THERAPEUTICS, INC. Director · 1 trade LSTA LISATA THERAPEUTICS, INC. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS NewAmsterdam Pharma Co N.V.
14 Sep 2026
Chief Executive Officer
Bought
10,000
$226.50K
1.3%
NAMS NewAmsterdam Pharma Co N.V.
2 Mar 2026
Chief Executive Officer
Sold at will
443,707
$14.75M
71.8%
NAMS NewAmsterdam Pharma Co N.V.
26 Feb 2026
Chief Executive Officer
Sold on a plan
183,332
$6.18M
51.3%
NAMS NewAmsterdam Pharma Co N.V.
25 Feb 2026
Chief Executive Officer
Sold on a plan
58,253
$2.06M
11.2%
NAMS NewAmsterdam Pharma Co N.V.
24 Feb 2026
Chief Executive Officer
Sold on a plan
64,708
$2.34M
12.3%
NAMS NewAmsterdam Pharma Co N.V.
7 Jan 2026
Chief Executive Officer
Sold on a plan
11,582
no price
3.0%
NAMS NewAmsterdam Pharma Co N.V.
26 Mar 2025
Chief Executive Officer
Sold at will
12,258
no price
3.0%
NAMS NewAmsterdam Pharma Co N.V.
20 Aug 2024
Chief Executive Officer
Bought
5,000
$81.35K
2.4%
TENX TENAX THERAPEUTICS, INC.
8 Aug 2024
Director
Bought
2,500
no price
656%
NAMS NewAmsterdam Pharma Co N.V.
20 Jun 2024
Chief Executive Officer
Bought
5,000
$86.31K
2.5%
LSTA LISATA THERAPEUTICS, INC.
9 Sep 2020
Director
Bought
55,525
$99.95K
109%
11 decisions on file.